Exogenous soluble tumor necrosis factor receptor type I ameliorates murine experimental autoimmune neuritis-Reference-Cited by-同舟云学术

Exogenous soluble tumor necrosis factor receptor type I ameliorates murine experimental autoimmune neuritis

Published:2003-02 Issue:1 Volume:12 Page:73-81
ISSN:0969-9961
Container-title:Neurobiology of Disease
language:en
Short-container-title:Neurobiology of Disease

Author:

Bao Lei,Lindgren J.Urban,Zhu Yu,Ljunggren Hans-Gustaf,Zhu Jie

Publisher

Elsevier BV

Subject

Neurology

Reference50 articles.

1. Stabilization of the bioactivity of tumour necrosis factor by its soluble receptors;Aderka;J. Exp. Med.,1992

2. Impairment of TNF-receptor-1 signaling but not fas signaling diminishes T-cell apoptosis in myelin oligodendrocyte glycoprotein peptide-induced chronic demyelinating autoimmune encephalomyelitis in mice;Bachmann;Am. J. Pathol.,1999

3. Control established experimental allergic encephalomyelitis by inhibition of tumor necrosis factor (TNF) activity within the central nervous system using monoclonal antibodies and TNF-receptor immunoglobulin fusion proteins;Baker;Eur. J. Immunol.,1994

4. The critical role of IL-12p40 in initiating, enhancing and perpetuating pathogenic events in murine experimental autoimmnue neuritis;Bao;Brain Pathol,2002

5. Effects of PEGylated soluble tumor necrosis factor receptor type I (PEG sTNF-RI) alone and in combination with methotrexate in adjuvant arthritic rats;Bendele;Clin. Exp. Rheum.,1999

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Apoptotic cell death in disease—Current understanding of the NCCD 2023;Cell Death & Differentiation;2023-04-26

2. Immune-Mediated Neuropathies: Pathophysiology and Management;International Journal of Molecular Sciences;2023-04-14

3. Biological Drugs in Guillain-Barré Syndrome: An Update;Current Neuropharmacology;2017-08-28

4. Attenuation of experimental autoimmune neuritis with locally administered lovastatin‐encapsulating poly(lactic‐co‐glycolic) acid nanoparticles;Journal of Neurochemistry;2016-12-20

5. Tumor necrosis factor-α in Guillain-Barré syndrome, friend or foe?;Expert Opinion on Therapeutic Targets;2016-11-18